27 de diciembre de 2026
FDA PDUFA target action date for relutrigine, a NDA from Praxis Precision Medicines. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
Calendario de Fechas de decisión PDUFA de la FDA